AstraZeneca Trixeo Wins EU Approval for Asthma Treatment
Cambridge, United Kingdom, September 23, 2026 AstraZeneca has announced that Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate dihydrate) has received European Commission...
Drug Approval
Advertisement
Alfasigma Gains Positive CHMP Opinion for Filgotinib in axSpA
MILAN, Italy — September 18, 2026 Alfasigma announced that the Committee for Medicinal Products for Human Use (CHMP) of...
Amarin Highlights New REDUCE-IT Data at ESC 2026
DUBLIN and BRIDGEWATER, N.J., August 31, 2026 Amarin Corporation plc highlighted new findings from multiple REDUCE-IT® analyses presented at...
PharmaEssentia Wins FDA Approval for BESREMi in ET
BURLINGTON, Mass., August 31, 2026 PharmaEssentia announced that the U.S. Food and Drug Administration (FDA) has approved BESREMi® (ropeginterferon...
Protagonist Therapeutics Wins FDA Approval for MIMRYLO
Protagonist Therapeutics, Newark, California, August 28, 2026 Protagonist Therapeutics announced that the U.S. Food and Drug Administration (FDA) has...
Advertisements
United Therapeutics Advances PAH and IPF Data at ESC, ERS
SILVER SPRING, Maryland & RESEARCH TRIANGLE PARK, North Carolina, Aug 28, 2026 United Therapeutics Corporation announced that new clinical...
Takeda Wins Japan Approval for ORZEYFUL in Narcolepsy
OSAKA, Japan & CAMBRIDGE, Massachusetts, Aug 24, 2026 Takeda Pharmaceutical Company Limited announced that Japan’s Ministry of Health, Labour...
GSK Wins Japan Approval for Hibsago in Hepatitis B
LONDON, UK, Aug 24, 2026 GSK plc announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved...
Teva Bids for BioXcel’s BXCL501 in Potential At-Home Agitation Treatment Deal
Tel Aviv, Israel – August 28, 2026 Teva Pharmaceutical Industries announced that it has entered into an agreement to...
United Therapeutics’ Ralinepag NDA Accepted by FDA
SILVER SPRING, Maryland & RESEARCH TRIANGLE PARK, North Carolina, Aug 24, 2026 United Therapeutics Corporation announced that the U.S....
Advertisement
